GCG and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss: These findings helped to identify GLP-2 as a possible therapeutic agent for the treatment of gastrointestinal diseases, such as short bowel syndrome (SBS), inflammatory bowel disease, and chemotherapy-induced mucositis.